MMP9 and Alzheimer disease: Recently, Bruno et al. [60] reported that, in a transgenic mouse Alzheimer's disease model, minocycline could diminish altered matrix metalloproteinase 9, an enzyme of NGF degradation, suggesting that minocycline may affect extracellular concentration of NGF in the cell culture.